Skip to main content
. 2021 Nov 2;12:734671. doi: 10.3389/fphar.2021.734671

TABLE 6.

Chi-square analysis of the incidence of VT among different dose groups.

Compound Dose (mg/kg) VT (frequency) Without VT (frequency) χ 2 p
Compound 1 0.05–0.20 18 3 14.704 0.001
0.40 6 4
0.60 2 9
Compound 2 0.05 9 2 13.000 0.002
0.20–0.30 13 8
0.40 1 9
Compound 4 0.05–0.20 18 3 10.165 0.001
0.40 7 12